Phys Vivas · infectious
Sexually Transmitted Infections — Viva Defence
DCE viva defence for Sexually Transmitted Infections.
On this page
Study tools
Target exams
Sexually Transmitted Infections Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Sexually Transmitted Infections. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]
Examiner questions
Q1: "What makes this urgent?" [1]
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]
Q2: "What is your first investigation package?" [2]
"I order tests that change management now, not a scattergun panel." [1] [2]
Q3: "Walk me through treatment." [1]
"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]
Q4: "What is the classic trap?" [2]
"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]
References6ShowHide
- [1]Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep, 2021.PMID 34292926
- [2]Unemo M, Seifert HS, Hook EW 3rd, et al. Gonorrhoea. Nat Rev Dis Primers, 2019.PMID 31754194
- [3]Barbee LA, St Cyr SB Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guidelines. Clin Infect Dis, 2022.PMID 35416971
- [4]Chevalier FJ, Bacon O, Johnson KA, et al. Syphilis: A Review. JAMA, 2025.PMID 41100079
- [5]Hamill MM, Ghanem KG, Tuddenham S State-of-the-Art Review: Neurosyphilis. Clin Infect Dis, 2024.PMID 37593890
- [6]Wood GE, Bradshaw CS, Manhart LE Update in Epidemiology and Management of Mycoplasma genitalium Infections. Infect Dis Clin North Am, 2023.PMID 37105645